Sequential liquid biopsy analysis of the NOSTRA-Feasibility study (HER2+/ER-) shows correlation between ctDNA clearance and pathological complete response after neoadjuvant chemotherapy and dual targeted therapy ISRCTN 17170034, Closed, Sponsor: University of Birmingham
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Fields of Study & Subjects
Cancer Genomics and Diagnostics
HER2/EGFR in Cancer Research
BRCA gene mutations in cancer
Publication details
- Journal / source
- European Journal of Cancer
- Volume
- 237
- Pages
- 116516–116516
- Publication date
- 1 March 2026
- Language
- EN